Navigation Links
Align Technology Names Dana C. Cambra as VP, Research & Development
Date:5/19/2008

SANTA CLARA, Calif., May 19 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN), today announced that it has hired Dana C. Cambra as vice president of research and development, effective June 16. Mr. Cambra will report directly to Align President and Chief Executive Officer, Thomas M. Prescott and lead the Company's research and development initiatives.

"Product innovation is Align's highest priority and we are pleased to have Dana on board to lead the team responsible for developing and executing our research initiatives and product roadmap," said Thomas M. Prescott, Align president and CEO. "Dana's extensive experience in medical technology and software development will be of tremendous value to Align as we continue our history of innovation and build the next generation of Invisalign products."

Innovation has been a hallmark of Mr. Cambra's career. As a member of the management and technical teams at Acuson Corporation, now a Siemens Company, he was instrumental in the development of the Sequoia Medical Diagnostic Ultrasound system, a breakthrough in high-resolution ultrasound products that has generated more than $4 billion in revenue.

More recently, Mr. Cambra served as senior vice president, research and development for Pharsight Corporation, a leading provider of simulation and modeling software for pharmaceutical and biotechnology companies. Prior to his role at Pharsight, Mr. Cambra was vice president, engineering at Stentor Inc. and the Phillips Global PACS business unit, an industry leader in providing medical informatics solutions. Earlier roles included senior engineering and operations positions at Visto, where he led development of communications solutions for the first Handspring/Palm Treo device, and iScribe, where he led the development of an industry leading ePrescribing solution.

Mr. Cambra received his undergraduate degrees in mathematics and engineering from MIT and his graduate degree in engineering from UC Berkeley.

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and older teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.

To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit http://www.invisalign.com or call 1-800-INVISIBLE.

Investor Relations Contact Press Contact

Shirley Stacy Shannon Mangum Henderson

Align Technology, Inc. Ethos Communication, Inc.

(408) 470-1150 (678) 540-9222

sstacy@aligntech.com align@ethoscommunication.com


'/>"/>
SOURCE Align Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. US Oncology Applauds Journal of Clinical Oncology Study Highlighting Value of PET Scans for Cancer Patients With Various Types of Malignancies
2. NUCRYST Announces Management Realignment and R&D Portfolio Change
3. New regulatory circuit identified for aggressive, malignant brain tumor
4. Malignant tumor or benign cyst?
5. Is Cancer Community in Alignment About Cure and Costs? NCCN Conference Panel Asks
6. Protein in Human Embryonic Stem Cells Controls Malignant Tumor Cells
7. Protein in embryonic stem cells control malignant tumor cells
8. ULLICO Casualty Group Aligns with Hudson Insurance Company to Offer Fiduciary and Union Liability Insurance
9. Alessi Skin Care Aligns With Celebrity Socialite Fabian Basabe to Raise Awareness for Their Face Forward Campaign
10. InterComponentWare Inc. Aligns with the Center for Health Transformation
11. Align Technology Executives to Present at Upcoming Financial Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology: